Pardo AS, Rojas CE, Jiménez-Arredondo RE, Velasco GLE, Rivera PME

Language: Spanish
References: 13
Page: 127-132
PDF size: 177.21 Kb.

ABSTRACT

Objective: To analyze the factors correlated with the perception in relation to the pharmacological management of insulin in diabetic patients. Methods: Analytical cross-sectional survey in people over 18 years of age with type 2 diabetes mellitus. The insulin treatment perception scale was applied to them. Inferential analysis with χ². Results: 360 patients were included, the female sex predominated, regarding the perception of pharmacological treatment with insulin, 55% agreed or totally agreed with the application of insulin and 45% disagreed or totally disagreed. Conclusions: There is a good perception of the use of insulins, however, there are factors that can intervene in a negative perception of their use.

REFERENCES

1. Orozco-Murillo HM, Jimena Rosales-Domínguez N, Orozco-López M, Stefanía Torres-Zatarain P, Calarco-Zaccari E, Héctor Manuel Orozco-Murillo L, et al. Artículo de Revisión México y el Mundo: un Contraste en la Insulinoterapia. Revista de Medicina Clínica • Año. 2018;115–22.

2. Rivas-Acuña M, María R. Prevalencia de ansiedad y depresión en las personas con diabetes mellitus tipo 2. SALUD EN TABASCO [Internet]. 2011;17(1–2):30–5. Available from: http://www.redalyc.org/articulo.oa?id=48721182005

3. Ortiz M, Ortiz E. Psicología de la salud: Una clave para comprender el fenómeno de la adherencia terapéutica. Rev Méd Chile. 2007;135:647–52.

4. Martín Alfonso L. Repercusiones para la salud pública de la adherencia terapéutica deficiente. Revista Cubana de Salud Pública [Internet]. 2006 [cited 2021 Dec 20];32(3):0–0. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662006000300013&lng=es&nrm=iso&tlng=es

5. Organización Mundial de la Salud. Diabetes [Internet]. 2021 [cited 2021 Dec 19]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/diabetes

6. Nunes V, Neilson J, O’Flynn N, Calvert N, Kuntze S, Smithson H, et al. Medicines Adherence: involving patients in decisions about prescribed medicines and supporting adherence. ROYAL COLLEGE OF GENERAL PRACTITIONERS [Internet]. 2009;2–364. Available from: https://www.nice.org.uk/guidance/ncg76

7. Brateanu A, Russo-Alvarez G, Nielsen-Fuentes C. Starting insulin in patients with type 2 diabetes: An individualized approach. Cleveland Clinic Journal Of Medicine [Internet]. 2015 [cited 2021 Dec 19];82. Available from: https://www.intramed.net/contenidover.asp?contenidoID=87955

8. Lerman I. Barreras que dificultan la aplicación temprana de insulina en el paciente con diabetes tipo 2. ALAD. 2009; XVII(2):66–8.

9. Snoek FJ, Skovlund SE, Pouwer F. Health and Quality of Life Outcomes Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Health and Quality of Life Outcomes [Internet]. 2007;5(69). Available from: http://www.hqlo.com/content/5/1/69

10. Leyva Jiménez R, Hernández Zambrano G, Ibarra Maldonado S, Ibarra Ramírez CT. Percepción de la insulinoterapia en pacientes con diabetes mellitus tipo 2 descontrolada. Aten Primaria. 2016 Oct 1;48(8):543–9.

11. Chen CC, Chang MP, Hsieh MH, Huang CY, Liao LN, Li TC. Evaluation of perception of insulin therapy among Chinese patients with type 2 diabetes mellitus. Diabetes & Metabolism. 2011 Nov 1;37(5):389–94.

12. Abu Hassan H, Tohid H, Mohd Amin R, Long Bidin MB, Muthupalaniappen L, Omar K. Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: A qualitative exploration. BMC Family Practice. 2013;14;164-74.

13. Hermanns N, Mahr M, Kulzer B, Skovlund SE, Haak T. Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study. Health and Quality of Life Outcomes2010 [Internet]. 2010;8(113). Available from: http://www.hqlo.com/content/8/1/113